123 related articles for article (PubMed ID: 25831728)
21. Neurologic, pulmonary, and cutaneous toxicities of high-dose chemotherapy.
Armstrong T; Rust D; Kohtz JR
Oncol Nurs Forum; 1997; 24(1 Suppl):23-33. PubMed ID: 9010862
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy.
Dawood S
Cancer Invest; 2009 Oct; 27(8):809-15. PubMed ID: 19731103
[No Abstract] [Full Text] [Related]
23. Closed system drug transfer devices for chemotherapy.
Kunneva L
Nursing; 2016 Jan; 46(1):67-8. PubMed ID: 26692315
[No Abstract] [Full Text] [Related]
24. Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.
Ulcickas Yood M; Bortolini M; Casso D; Beck JG; Oliveria SA; Wells KE; Woodcroft KJ; Wang LI
Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):427-34. PubMed ID: 25683797
[TBL] [Abstract][Full Text] [Related]
25. [Anemia and lung cancer].
Bréchot JM; Morère JF
Rev Pneumol Clin; 2008 Apr; 64(2):81-4. PubMed ID: 18589288
[TBL] [Abstract][Full Text] [Related]
26. Late toxic effects of cytotoxic drugs.
Fortuny IE; Theologides A
Minn Med; 1974 Jan; 57(1):19-21 passim. PubMed ID: 4592758
[No Abstract] [Full Text] [Related]
27. [Principle and practice of clinical phase III studies].
Morant R
Onkologie; 2008; 31 Suppl 2():53-7. PubMed ID: 18487870
[TBL] [Abstract][Full Text] [Related]
28. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!
Kemeny NE
Important Adv Oncol; 1992; ():207-27. PubMed ID: 1533847
[No Abstract] [Full Text] [Related]
29. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
30. Hepatotoxicity of chemotherapy.
Sachs B; Haider S; Balaraman R; Shahab N; Perry MC
Expert Opin Drug Saf; 2002 Nov; 1(4):339-53. PubMed ID: 12904134
[TBL] [Abstract][Full Text] [Related]
31. Risk of miscarriage is increased for nurses handling chemotherapy.
McBride D
ONS Connect; 2012 Apr; 27(4):22. PubMed ID: 22662588
[No Abstract] [Full Text] [Related]
32. Promising new treatment schedule for gefitinib responders after severe hepatotoxicity with daily administration.
Seki N; Uematsu K; Shibakuki R; Eguchi K
J Clin Oncol; 2006 Jul; 24(19):3213-4; author reply 3214-5. PubMed ID: 16809744
[No Abstract] [Full Text] [Related]
33. Part I: Liver function in oncology: biochemistry and beyond.
Field KM; Dow C; Michael M
Lancet Oncol; 2008 Nov; 9(11):1092-101. PubMed ID: 19012858
[TBL] [Abstract][Full Text] [Related]
34. [Safety management in the outpatient chemotherapy unit].
Yanagihara K; Matsumoto R; Kurahashi M
Nihon Rinsho; 2015 Feb; 73 Suppl 2():63-6. PubMed ID: 25831725
[No Abstract] [Full Text] [Related]
35. [Hepatotoxicity of chemotherapy].
Okamoto R; Maeda Y; Sasaki T
Nihon Rinsho; 2003 Jun; 61(6):978-83. PubMed ID: 12806946
[TBL] [Abstract][Full Text] [Related]
36. Principles of chemotherapy safety procedures.
Takada S
Clin Tech Small Anim Pract; 2003 May; 18(2):73-4. PubMed ID: 12831064
[TBL] [Abstract][Full Text] [Related]
37. [High-dose chemotherapy: principles, indications and complications].
Göbel U; Jürgens H; Schwamborn D; Wahn V
Klin Padiatr; 1988; 200(1):1-6. PubMed ID: 3285085
[TBL] [Abstract][Full Text] [Related]
38. Diversity in renal function monitoring and dose modifications during treatment for childhood cancer: a call for standardization.
Blufpand HN; Hes N; Bökenkamp A; van de Wetering MD; Kaspers GJ
Pediatr Blood Cancer; 2014 Feb; 61(2):337-44. PubMed ID: 23907811
[TBL] [Abstract][Full Text] [Related]
39. [Principles and practice of clinical phase I studies].
Hanauske AR
Onkologie; 2008; 31 Suppl 2():39-45. PubMed ID: 18487868
[TBL] [Abstract][Full Text] [Related]
40. [Respiratory complications of anticancer chemotherapy].
Leclerc P; Robillard M
Rev Pneumol Clin; 1986; 42(3):142-9. PubMed ID: 3534991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
